Research connecting PFAS exposure and liver cancer
Researchers from the Keck School of Medicine at the University of Southern California reported that elevated levels of certain PFAS types can lead to an increased risk of developing HCC. They studied 100 plasma samples and found that those with higher concentrations of perfluorooctanesulfonic acid (PFOS), a PFAS chemical compound, are 4.5 times more likely to develop HCC.
Another study from the Journal of Hepatology (JHEP) Reports indicates that higher concentrations of PFAS in the bloodstream can increase the risk of non-alcoholic fatty liver disease (NAFLD) among U.S. adults. NAFLD is considered a precursor to liver cancer, specifically HCC. When left untreated, it can progress to non-alcoholic steatohepatitis (NASH) and further result in cirrhosis and liver cancer.
Both studies also affirm findings from the Environmental Protection Agency (EPA) that PFAS exposure can increase the risk of developing certain forms of cancer. Because of their persistent nature, PFAS can stay in the body for a long time and have the tendency to accumulate in cells and organs, including the liver.
ELG Law can help you file your PFAS liver cancer claim
We've worked with victims of toxic exposure claims for over 35 years. If you or a loved one has liver cancer and a possible history of PFAS exposure, you might be eligible for a toxic exposure claim. You can reach out to our team of attorneys, who will guide you through every step of the process, from evaluating your case to taking the steps needed to get the compensation you deserve.
